Skip to Content Facebook Feature Image

Hong Leong Bank Named 'Best SME Bank in Malaysia' by The Asian Banker, Driven by Strong Loan Growth Rate and Customer-Focused Innovations

Business

Hong Leong Bank Named 'Best SME Bank in Malaysia' by The Asian Banker, Driven by Strong Loan Growth Rate and Customer-Focused Innovations
Business

Business

Hong Leong Bank Named 'Best SME Bank in Malaysia' by The Asian Banker, Driven by Strong Loan Growth Rate and Customer-Focused Innovations

2025-06-10 18:23 Last Updated At:18:45

KUALA LUMPUR, Malaysia, June 10, 2025 /PRNewswire/ -- Building on its consistent excellence and deep commitment to the SME ecosystem, Hong Leong Bank ("HLB" or "the Bank") has been named the Best SME Bank in Malaysia for the sixth time at The Asian Banker Global Excellence in Retail Finance Awards 2025. This accolade is a testament to HLB's enduring history of delivering industry-leading SME banking solutions that serve its customers' diversified needs.

The Bank continues to record strong strides in its SME banking sector, achieving a commendable 8.5% year-on-year ("y-o-y") growth in SME loans and expanding the Bank's SME loan book to RM36 billion as of March 2025. This sustained growth has also strengthened HLB's overall performance, with SME banking now contributing 12.1% to the total Bank's revenue and Profit Before Tax (PBT) rising to 12.6% in March 2025.

According to Kevin Lam, Group Managing Director and CEO of HLB, the strength of the Bank's SME segment highlights HLB's commitment to supporting its customers towards achieving their business objectives.

"The global economic landscape is characterised by continuous change, presenting businesses with a spectrum of opportunities and complexities as we witness the unfolding of a 'new trade world order'. And on these geoeconomic crossroads, we believe in proactively equipping our SME customers with the necessary resources and strategic support, regardless of global shifts in trade or market sentiment. The consistent positive momentum within our SME banking segment is powerful evidence of our commitment, demonstrating the strength of our long-term partnerships with our customers, enabling them to confidently pursue their diversified business objectives with our comprehensive suite of bespoke business banking solutions."

HLB's recognition as the Best SME Bank in Malaysia reflects its comprehensive approach to supporting its SME customers, combining digital innovation and tailored solutions to ensure a seamless customer experience boosted by strategically-integrated digital efficiencies. Expanding on the Bank's own tablet-based onboarding feature, one key advancement in HLB's business banking solutions is the Partnership Onboarding feature, which allows SME customers to onboard partnership entities directly in-branch, providing more flexibility and convenience for partnerships seeking banking services with HLB while allowing the Bank to accommodate a wider range of business structures. The in-branch tablet-based onboarding feature can now also be used to support the opening of Foreign Currency Accounts ("FCA"), providing further convenience for businesses dealing in foreign markets.

HLB has also enabled businesses to validate their LHDN registration number via an LHDN API, allowing customers to make statutory payments through the Hong Leong ConnectFirst ("HLCF") platform. With this enhancement, customers can conveniently register their LHDN number directly at HLB branches, simplifying compliance with regulatory requirements.

According to Yow Kuan Tuck, HLB's Managing Director of Business & Corporate Banking, the consistent positive growth among HLB's SME segment underscores its dedication to designing tailor-made banking solutions that are innovative, efficient, and cater to customers' unique business needs.

"HLB has a long history of working closely with our customers to deliver tailor-made solutions that cater specifically to their diversified business needs. In supporting our SME customers in their business growth, we have consistently integrated technological advancements and innovative digital solutions to simplify certain processes and execute tasks more efficiently and effectively. From introducing the in-branch tablet-onboarding feature, to launching our digital business banking platform and integrating features such as cash flow analytics and automated transactions, our banking solutions serve to empower SMEs to scale, pivot, and compete in today's economy."

This latest accolade builds on the Bank's previous win in 2023, and this consistency has also been celebrated across the industry, notably with HLB being named Best SME Bank in Malaysia for three consecutive years at the Asian Banking & Finance Retail Banking Awards, and receiving top honours at the Euromoney Awards for Excellence 2024.

To know more about HLB's SME banking solutions, please visit: https://www.hlb.com.my/en/business-banking/group-sme-banking.html

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Hong Leong Bank Named 'Best SME Bank in Malaysia' by The Asian Banker, Driven by Strong Loan Growth Rate and Customer-Focused Innovations

Hong Leong Bank Named 'Best SME Bank in Malaysia' by The Asian Banker, Driven by Strong Loan Growth Rate and Customer-Focused Innovations

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors

Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer

Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.

"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."

Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.

 

 

To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.

Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.

"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."

About Alamar Biosciences, Inc. 
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com

 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Recommended Articles